Methods for producing hyaluronan in a recombinant host cell

Details for Australian Patent Application No. 2002366711 (hide)

Owner Novozymes Biopolymer A/S

Inventors Widner, William; Tang, Maria; Behr, Regine; Brown, Stephen; Sternberg, David; Sloma, Alan

Agent Spruson & Ferguson

Pub. Number AU-B-2002366711

PCT Number PCT/US02/41067

PCT Pub. Number WO2003/054163

Priority 60/342,644 21.12.01 US

Filing date 20 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 29 November 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/04 (2006.01) Enzymes, e.g. ligases (6.) - acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12N 15/53 (2006.01) Mutation or genetic engineering - Oxidoreductases (1)

C12N 15/54 (2006.01) Mutation or genetic engineering - Transferases (2)

C12N 15/61 (2006.01) Mutation or genetic engineering - Isomerases (5)

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 19/04 (2006.01) Preparation of compounds containing saccharide radicals

C12P 19/26 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/342,644 21.12.01 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002366711

29 November 2007 Application Accepted

  Published as AU-B-2002366711

3 April 2008 Standard Patent Sealed

7 August 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 25 Mar 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

22 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 02 Jan 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

22 January 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 25 Mar 2008 2003

25 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Jan 2009 2003

16 July 2009 Assignment Registered

  Novozymes Biopolymer A/S The patent has been assigned to Novozymes Biopharma DK A/S

16 August 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 10 Jul 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002366712-GENETIC MARKERS AND METHODS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF TUMOR METASTASIS

2002366710-USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS